Waleed Ghanima

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint [Hairy cell leukemia treated with cladribine]
    Waleed Ghanima
    Seksjon for blodsykdommer Medisinsk avdeling Rikshospitalet 0027 Oslo
    Tidsskr Nor Laegeforen 122:1094-7. 2002
  2. ncbi request reprint Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
    Waleed Ghanima
    Medical Department, Section of Haematology, Østfold Hospital, Fredrikstad, Fredrikstad, Norway
    Eur J Haematol 72:441-3. 2004
  3. doi request reprint Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
    Waleed Ghanima
    Department of Pediatric Hematology Oncology, Weill Cornell Medical College, New York, NY 10065, USA
    Br J Haematol 155:248-55. 2011
  4. doi request reprint Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities
    Leonardo Boiocchi
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA
    Mod Pathol 25:65-74. 2012
  5. doi request reprint How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
    Waleed Ghanima
    Department of Pediatric Hematology Oncology, Weill Cornell Medical College, New York, NY 10065, USA
    Blood 120:960-9. 2012
  6. doi request reprint Thrombopoietic agents in immune thrombocytopenia
    Waleed Ghanima
    Department of Medicine, Østfold Hospital Trust Fredrikstad, Fredrikstad, Norway
    Semin Hematol 47:258-65. 2010

Collaborators

Detail Information

Publications6

  1. ncbi request reprint [Hairy cell leukemia treated with cladribine]
    Waleed Ghanima
    Seksjon for blodsykdommer Medisinsk avdeling Rikshospitalet 0027 Oslo
    Tidsskr Nor Laegeforen 122:1094-7. 2002
    ..Hairy cell leukaemia is a chronic B-cell disorder that follows an indolent course. Cladribine has in the last decade emerged as the drug of choice for treating hairy cell leukaemia...
  2. ncbi request reprint Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
    Waleed Ghanima
    Medical Department, Section of Haematology, Østfold Hospital, Fredrikstad, Fredrikstad, Norway
    Eur J Haematol 72:441-3. 2004
    ..Fifteen months later, she was still enjoying a major cytogenetic response. This case illustrates that a short course of imatinib mesylate may result in a sustained haematological and cytogenetic response...
  3. doi request reprint Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
    Waleed Ghanima
    Department of Pediatric Hematology Oncology, Weill Cornell Medical College, New York, NY 10065, USA
    Br J Haematol 155:248-55. 2011
    ..In conclusion, low-grade BM reticulin fibrosis is seen in most ITP patients on Tpo-RA. The novel findings of decreasing PIIINP and elevated HGF need further investigation to explore their significance in BM fibrogenesis...
  4. doi request reprint Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities
    Leonardo Boiocchi
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA
    Mod Pathol 25:65-74. 2012
    ....
  5. doi request reprint How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
    Waleed Ghanima
    Department of Pediatric Hematology Oncology, Weill Cornell Medical College, New York, NY 10065, USA
    Blood 120:960-9. 2012
    ..As each approach has advantages and disadvantages, treatment needs to be individualized, and patient participation in decision-making is paramount...
  6. doi request reprint Thrombopoietic agents in immune thrombocytopenia
    Waleed Ghanima
    Department of Medicine, Østfold Hospital Trust Fredrikstad, Fredrikstad, Norway
    Semin Hematol 47:258-65. 2010
    ..Several other agents are currently being investigated and are in preclinical and clinical development programs...